ArticleScientific reports2024
The Temozolomide-Doxorubicin paradox in Glioblastoma in vitro-in silico preclinical drug-screening.
Mariam-Eleni Oraiopoulou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it